The latest closing stock price for Alnylam Pharmaceuticals as of June 04, 2025 is 305.31.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $49,800 today, roughly 50 times their original investment - a 20.57% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 306.09 on June 02, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 308.93, which is 1.2% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 51.8% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 256.26.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $49,800 today, roughly 50 times their original investment - a 20.57% compound annual growth rate over 21 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 306.09 on June 02, 2025.
The Alnylam Pharmaceuticals 52-week high stock price is 308.93, which is 1.2% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 147.25, which is 51.8% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 256.26.